Pharma's Market

PHARMA WATCH LIST

SPECIAL REPORT

Healthy Horizons
A brand new series of weekly segments which will explore the macro and micro issues facing the global economy.

LATEST FROM OUR BLOGS

» More

- News Corp. Beats Estimates on Studio, Cable Strength

TOP HEADLINES

» Markets | Economy | Companies

- Traders to Watch Jobless Claims for Signs of Recovery

PHARMA'S MARKET VIDEO

» More

Wall Street Protests 29 Apr 2010
Following a big demonstration in favor of financial regulation right outside the NYSE, with CNBC's Mike Huckman.
March on Wall Street 29 Apr 2010
Main Street takes to Wall Street today with thousands of union community activists marching to make the big banks pay, with CNBC's Mike Huckman.
Mike Huckman: Reporter's Reporter 29 Apr 2010
Original air date, June 26, 2002.
SBUX Beats the Street 21 Apr 2010
CNBC's Mike Huckman has Starbucks' earnings breakdown.

The Orange Squeeze on Dimon

16 Apr 2010

Some students at Syracuse University have a different idea rather than having JPMorgan's chairman/CEO Jamie Dimon deliver this year's commencement speech, reports CNBC's Mike Huckman.

Nasdaq Outperforms 14 Apr 2010
The Nasdaq easily outperforming the other major indexes today, with CNBC's Mike Huckman.

RSS FEED

» Help

Subscribe to this RSS feed
Stay up to date with Pharma's Market.

Dendreon: Did Provenge Spark Early Fireworks?

Published: Tuesday, 3 Jul 2007 | 11:56 AM ET

Text Size

By: Mike Huckman
Reporter

TheStreet.com picked DNDN as its top "Rocket Stock of the Week after huge options activity last Wednesday when I blogged about the sudden mid-afternoon spike in DNDN shares. But I doubt this is the event investors might have been anticipating. My producer, Ruth, who usually gets embargoed publications of medical studies at least a few days in advance, didn't see this one come into her inbox until late yesterday. The embargo lifted at midnight last night.

Click for related content

Dendreon Announces FDA Advisory Committee Reviewed Provenge® for Hormone Refractory Prostate Cancer

There are several biotech companies working on therapeutic cancer vaccines--all of them micro-caps--including CEGE [CEGE Loading... () ] , FVRL [FVRL Loading... () ], GTOP [GTOP Loading... () ] , AGEN [AGEN Loading... () ] and BIOM [BIOM Loading... () ] . In the meantime, a new chemotherapy drug for prostate cancer, Satraplatin, goes before an FDA Advisory Committee on July 25th and is scheduled for an FDA decision the middle of next month. GPCB [GPCB Loading... () ] , SPPI [SPPI Loading... () ] and PHRM [PHRM Loading... () ] are in a three-way partnership on that drug which, interestingly, Bristol-Myers Squibb [BMY Loading... () ] used to own, but gave back to Spectrum.